Feature Article

Body Dysmorphic Disorder: Ethical Questions and Surgical Contraindications

By

The potential consequences of providing cosmetic treatment to a patient with BDD can extend beyond ethical concerns.

The relative risk for healthcare-associated infections has decreased in the last 15 years due to improvements in awareness of risk associated with devices, infection control, and evidence-based practice regarding use of devices.

Latest News

Personal Care Products: What Patients Should Know About Shaving, Detergents, and More

By

Detergents labeled as dye- and fragrance-free may be the best option for certain patients.

Treatment for WHIM Syndrome Gets Orphan Drug Designation

By

X4 Pharmaceuticals is developing the drug, which is currently in a Phase 2/3 clinical trial involving patients with WHIM syndrome.

Topical Cantharidin Safe and Effective for Warts and Molluscum Contagiosum

By

Topical cantharidin showed high efficacy and safety for the treatment of warts, especially when used with podophyllotoxin and salicylic acid.

Treating Chronic Itch: Therapeutic Review

By

Itch is "learned" in the nervous system, said Dr Berger, with involvement by both central and peripheral neural processes.

Solutions for Hyperhidrosis: Newly Approved Treatments and Research Update

By

Newly approved treatment options for axillary hyperhidrosis give more opportunities for clinicians to provide personalized treatment for patients.

Topical Liposomal Hydroquinone vs Conventional Treatments for Melasma: Which Is Better?

By

Liposomal hydroquinone has a significant therapeutic effect in patients with melisma but is not superior to conventional treatments.

Dermatoscopic Magnets Present No Safety Risk for Patients With CV-Implanted Electronic Devices

By

The safety risk of dermatoscope magnets in patients with cardiovascular implanted electronic devices was examined.

Active Pharmaceuticals ID'd in >700 Dietary Supplements

Dietary supplements often include active pharmaceuticals, even after warnings from the U.S. Food and Drug Administration.

Natural Products Superior to Synthetic, Dermatologist-Recommended Products for Sensitive Skin

By

The one area where synthetic products outperformed nature-based products was in hydration.

Estimates of Pemphigoid Prevalence in the United States Based on Age and Gender

By

Women 60 and older comprise the majority of cases of pemphigoid in the United States.

Nitric Oxide-Releasing Hydrogel SB208 Effective for Treating Tinea Pedis

By

SB208, a stable was shown to be well-tolerated and effective for the treatment of interdigital tinea pedis.

Accepted Manuscripts Meet More Criteria for Research Reporting

Accepted manuscripts for observational studies have better adherence to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist compared with rejected manuscripts.

Homocysteine, Folate, Vitamin B12 as Potential Biomarkers for Vitiligo

Investigators examined the role of serum homocysteine, folate, and vitamin B12 levels in patients with vitiligo.

The Open Access Debate: Should Patients Freely Access Research?

By

Patients and their families are advocating for their right to access the latest medical research papers to help find potential treatments and understand health conditions.

Recognizing Skin Popping Scars and the Benefits of Early Intervention

By Dermatology Advisor Contributing Writer

The case study underscores the significance of recognizing lesions associated with skin popping.

FDA Issues Safety Communication Regarding Pen Needle Use

By

Standard pen needles have an outer cover and removable inner needle cover, while safety pen needles have an outer cover and a fixed inner needle shield that is not removed before an injection.

Qbrexza Now Available for the Treatment of Primary Axillary Hyperhidrosis

By

A single cloth should be used to apply Qbrexza to both underarms.

FDA Requests Another Clinical Trial for Ruconest in HAE Prophylaxis

By

The Company filed the sBLA last November following FDA feedback on two completed Phase 2 trials of Ruconest for prophylaxis of HAE attacks.

Dozens of Medical Groups Join Forces to Improve Diagnoses

Every nine minutes, a patient in a U.S. hospital dies because a diagnosis was wrong or delayed -- resulting in 80,000 deaths a year.

Importance of Screening Skin Pigmentation Disorders in Systemic Sclerosis

By Dermatology Advisor Contributing Writer

Investigators examine the association between pigmentation disorders and systemic involvement in patients with systemic sclerosis.

Sign up for Newsletters